NCT07403084

Post-market Clinical Follow-up Study of NEMOST V2

Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: EUROS · Industry
• Sex: All
• Age: 5 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino. Retrospective and prospective multicenter post-market surveillance clinical study. This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The study will include 140 patients.

Conditions

• Scoliosis Neuromuscular
• Scoliosis Idiopathic
• Consent Forms

Interventions

Type	Name	Description
DEVICE	NEMOST V2 growing domino	The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.

Timeline

• Start date: 2025-12-19
• Primary completion: 2033-12-19
• Completion: 2033-12-19
• First posted: 2026-02-11
• Last updated: 2026-02-11

Locations

5 sites across 1 country: France